CD38 and neoplasm: CD38 antibodies kill tumor cells via Fc-dependent immune effector mechanisms including complement-dependent cytoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and apoptosis upon secondary cross-linking (4, 5, 15).